Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114271625 | 11427162 | 5 | F | 20150813 | 20160909 | 20150827 | 20160915 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-054905 | BRISTOL MYERS SQUIBB | 70.00 | YR | F | Y | 53.00000 | KG | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114271625 | 11427162 | 1 | PS | OPDIVO | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | UNK, Q2WK | U | U | 125554 | QOW | |||||||
| 114271625 | 11427162 | 2 | SS | OPDIVO | NIVOLUMAB | 1 | U | U | 125554 | ||||||||||
| 114271625 | 11427162 | 3 | SS | LYRICA | PREGABALIN | 1 | Unknown | U | 0 | ||||||||||
| 114271625 | 11427162 | 4 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 114271625 | 11427162 | 5 | C | MS CONTIN | MORPHINE SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 114271625 | 11427162 | 6 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Unknown | U | 0 | ||||||||||
| 114271625 | 11427162 | 7 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 325 MG, QD | U | 0 | 325 | MG | QD | ||||||
| 114271625 | 11427162 | 8 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | Unknown | U | 0 | ||||||||||
| 114271625 | 11427162 | 9 | C | ZOCOR | SIMVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 114271625 | 11427162 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114271625 | 11427162 | 1 | Non-small cell lung cancer |
| 114271625 | 11427162 | 2 | Lung neoplasm malignant |
| 114271625 | 11427162 | 3 | Product used for unknown indication |
| 114271625 | 11427162 | 4 | Product used for unknown indication |
| 114271625 | 11427162 | 5 | Product used for unknown indication |
| 114271625 | 11427162 | 6 | Product used for unknown indication |
| 114271625 | 11427162 | 7 | Product used for unknown indication |
| 114271625 | 11427162 | 8 | Product used for unknown indication |
| 114271625 | 11427162 | 9 | Product used for unknown indication |
| 114271625 | 11427162 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114271625 | 11427162 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114271625 | 11427162 | Adrenal gland cancer | |
| 114271625 | 11427162 | Cognitive disorder | |
| 114271625 | 11427162 | Cough | |
| 114271625 | 11427162 | Depression | |
| 114271625 | 11427162 | Fall | |
| 114271625 | 11427162 | Fatigue | |
| 114271625 | 11427162 | Pyrexia | |
| 114271625 | 11427162 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114271625 | 11427162 | 1 | 201507 | 0 |